CAPR
CAPRICOR THERAPEUTICS, INC.Company Information
- Company Name
- CAPRICOR THERAPEUTICS, INC.
- CIK
- CIK0001133869
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CAPR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CAPR
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-09-20
- Last sale
- 2026-06-25
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 210,264
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 33,428,338
- Shares outstanding
- 57,434,267
- Ownership
- 58.20%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 41.35%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 21 | 105 | 288 | 20 | 23 | 29 | 11 | 68 | 11 | 6 | 15 | 9 | ||||||
| Marketable Securities Current | - | - | - | 79 | 100 | 116 | 140 | 17 | 19 | 34 | 25 | 20 | ||||||
| Available For Sale Securities Debt Securities Current | 217 | 173 | 30 | - | - | - | 140 | - | - | - | - | - | ||||||
| Grants Receivable Current | - | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 10 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 5 | 2 | 1 | 1 | 2 | 0 | 1 | 1 | 1 | 0 | ||||||
| Assets Current | 242 | 283 | 323 | 101 | 124 | 146 | 163 | 86 | 31 | 41 | 51 | 30 | ||||||
| Property Plant And Equipment Net | 36 | 29 | 18 | 11 | 8 | 6 | 6 | 5 | 6 | 6 | 6 | 5 | ||||||
Other Assets | ||||||||||||||||||
| Operating Lease Right Of Use Asset | 89 | 13 | 14 | 14 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Other Assets | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 369 | 326 | 356 | 126 | 134 | 154 | 170 | 93 | 38 | 49 | 59 | 37 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 4 | 2 | 3 | 5 | 5 | 3 | - | - | - | - | - | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | 8 | 7 | 6 | 6 | 6 | 7 | ||||||
| Accrued Liabilities Current | 16 | 11 | 16 | 10 | 7 | 4 | 5 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Government Assistance Liability Current | 0 | 6 | 6 | 3 | 3 | - | 0 | - | - | - | - | - | ||||||
| Contract With Customer Liability Current | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 19 | 24 | 25 | ||||||
| Liabilities Current | 33 | 34 | 36 | 28 | 28 | 22 | 21 | 20 | 22 | 26 | 31 | 33 | ||||||
| Other Long Term Debt Noncurrent | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Government Assistance Liability Noncurrent | - | - | 0 | 0 | 0 | 3 | 3 | - | - | - | 3 | - | ||||||
| Operating Lease Liability Noncurrent | 90 | 14 | 14 | 14 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Liabilities Noncurrent | 90 | 14 | 14 | 14 | 0 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | ||||||
| Liabilities | 123 | 48 | 50 | 43 | 29 | 26 | 25 | 25 | 27 | 31 | 36 | 39 | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 626 | 618 | 610 | 358 | 354 | 350 | 344 | 261 | 191 | 187 | 182 | 157 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -380 | -339 | -305 | -275 | -250 | -224 | -200 | -193 | -180 | -169 | -159 | -159 | ||||||
| Stockholders Equity | 246 | 279 | 306 | 84 | 105 | 128 | 145 | 68 | 12 | 18 | 23 | -2 | ||||||
| Liabilities And Stockholders Equity | 369 | 326 | 356 | 126 | 134 | 154 | 170 | 93 | 38 | 49 | 59 | 37 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 58 | 58 | 57 | 46 | 46 | 46 | 46 | 40 | 32 | 32 | 31 | 26 | ||||||
| Shares Outstanding | 58 | 58 | 57 | 46 | 46 | 46 | 46 | 40 | 32 | 32 | 31 | 26 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCAPRICOR THERAPEUTICS, INC. (CAPR) — SEC Financial Statements & Analysis
CAPRICOR THERAPEUTICS, INC. (CAPR) is a pharmaceutical preparations company, incorporated in DE. CAPRICOR THERAPEUTICS, INC. trades on Nasdaq as: CAPR. CAPRICOR THERAPEUTICS, INC. (CAPR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, CAPRICOR THERAPEUTICS, INC. carries a market cap of $1.39B, a P/E ratio of -10.78x, a P/B ratio of 5.67x, a P/S ratio of 29.61x, an enterprise value of $1.37B, and an EV/EBITDA multiple of -10.33x. On profitability, it posts an operating margin of -778.77%, a net margin of -736.62%, a Return on Equity (ROE) of -73.70%, a Return on Assets (ROA) of -51.53%, and a Return on Invested Capital (ROIC) of -87.97%. Per share, it reports EPS of $-2.23, diluted EPS of $-2.23, free cash flow per share of $-1.98, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 84.94% year-over-year, and EPS growth of 45.94% year-over-year. On the balance sheet, it maintains a current ratio of 7.35x, a quick ratio of 7.22x, working capital of $209.17M, a debt-to-equity ratio of 0.50x, a debt ratio of 0.33, free cash flow of $-114.90M (TTM), and net debt of $-20.94M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.39B
- P/E TTM
- -10.78x
- EPS TTM
- $-2.23
- P/B TTM
- 5.67x
- ROE TTM
- -73.70%
- ROA TTM
- -51.53%
- Debt To Equity
- 0.50x
- Free Cash Flow TTM
- $-114.90M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CAPRICOR THERAPEUTICS, INC. in?
CAPRICOR THERAPEUTICS, INC. (CAPR) operates in the Pharmaceutical Preparations industry.
What exchange does CAPR trade on?
CAPRICOR THERAPEUTICS, INC. (CAPR) trades on the Nasdaq.
Where is CAPRICOR THERAPEUTICS, INC. incorporated?
CAPRICOR THERAPEUTICS, INC. is incorporated in DE.
When was CAPRICOR THERAPEUTICS, INC. (CAPR)'s most recent SEC filing?
CAPRICOR THERAPEUTICS, INC. (CAPR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is CAPR's market cap?
CAPRICOR THERAPEUTICS, INC. (CAPR) has a market capitalization of $1.39B as of 2026-06-30.
What is CAPR's EPS (earnings per share)?
CAPRICOR THERAPEUTICS, INC. (CAPR)'s trailing twelve month EPS is $-2.23 as of 2026-06-30.
What is CAPR's ROE (return on equity)?
CAPRICOR THERAPEUTICS, INC. (CAPR)'s trailing twelve month Return on Equity (ROE) is -73.70% as of 2026-06-30.
What is CAPR's ROA (return on assets)?
CAPRICOR THERAPEUTICS, INC. (CAPR)'s trailing twelve month Return on Assets (ROA) is -51.53% as of 2026-06-30.
What is CAPR's ROIC (return on invested capital)?
CAPRICOR THERAPEUTICS, INC. (CAPR)'s trailing twelve month Return on Invested Capital (ROIC) is -87.97% as of 2026-06-30.
What is CAPR's EV/EBITDA?
CAPRICOR THERAPEUTICS, INC. (CAPR)'s trailing twelve month EV/EBITDA is -10.33x as of 2026-06-30.